Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Changes within the "normal" cerebral white matter of multiple sclerosis patients during acute attacks and during high-dose cortisone therapy assessed by means of quantitative MRI.
Journal of neurology, neurosurgery, and psychiatry·1989
[Incidence and clinical importance of chronic reactive periosteal new bone formation in the cervical region in patients with differing neurologic symptomatology].
Rontgen-Blatter; Zeitschrift fur Rontgen-Technik und medizinisch-wissenschaftliche Photographie·1989
Structural brain correlates of anterograde memory deficits in multiple sclerosis.
Journal of neurology·1988
[Reversible opening of the blood-brain barrier in the chemotherapy of malignant gliomas].
Wiener klinische Wochenschrift·1987
Improving the specificity of digoxin immunoassays.
Wiener klinische Wochenschrift. Supplementum·1992
Economic aspects of therapeutic drug monitoring.
Wiener klinische Wochenschrift. Supplementum·1992
Results of the multicenter evaluation of the CEDIA cortisol assay.
Wiener klinische Wochenschrift. Supplementum·1992
An evaluation of a non-isotopic homogeneous enzyme immunoassay (CEDIA assay) for cortisol and its clinical utility.
Wiener klinische Wochenschrift. Supplementum·1992
Results of the multicenter evaluation of a homogeneous immunoassay for digitoxin based on the cloned enzyme donor immunoassay technology.
Wiener klinische Wochenschrift. Supplementum·1992
Results of the multicenter evaluation of a novel homogeneous immunoassay for digoxin based on the cloned enzyme donor immunoassay technology.
Wiener klinische Wochenschrift. Supplementum·1992
Targeting the nervous system: Mechanistic insights into neuro-tumor communication and therapeutic opportunities.
Acta pharmaceutica Sinica. B·2026
Wiring the developing brain: The Rho GTPase signaling network in neurodevelopmental disorders.
Neurobiology of disease·2026
Discovery of H-10 as a potent and safe GABAA receptor positive allosteric modulator: A novel benzothiazine-triazole lead compound with broad-spectrum anticonvulsant activity.
European journal of medicinal chemistry·2026